Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

Risk of secondary primary malignancies in multiple myeloma patients with or without autologous stem cell transplantation.

Yamasaki S, Yoshimoto G, Kohno K, Henzan H, Aoki T, Tanimoto K, Sugio Y, Muta T, Kamimura T, Ohno Y, Ogawa R, Eto T, Nagafuji K, Miyamoto T, Akashi K, Iwasaki H; Fukuoka Blood and Marrow Transplantation Group.

Int J Hematol. 2019 Jan;109(1):98-106. doi: 10.1007/s12185-018-2538-8. Epub 2018 Sep 24.

PMID:
30251131
2.

Tubular surgery with the assistance of endoscopic surgery via a paramedian or midline approach for lumbar spinal canal stenosis at the L4/5 level.

Komatsu J, Muta T, Nagura N, Iwabuchi M, Fukuda H, Kaneko K, Shirado O.

J Orthop Surg (Hong Kong). 2018 May-Aug;26(2):2309499018782546. doi: 10.1177/2309499018782546.

PMID:
29938605
3.

Breakthrough infection of Geotrichum capitatum during empirical caspofungin therapy after umbilical cord blood transplantation.

Oya S, Muta T.

Int J Hematol. 2018 Nov;108(5):558-563. doi: 10.1007/s12185-018-2481-8. Epub 2018 Jun 20.

PMID:
29926359
4.

Immune Checkpoint Inhibitor Therapy: A Boon to Elderly Patients with Advanced Melanoma?

Muta T.

Intern Med. 2018 Aug 15;57(16):2287-2288. doi: 10.2169/internalmedicine.0686-17. Epub 2018 Mar 30. No abstract available.

5.

Significance of Salvage Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma: A Nationwide Retrospective Study in Japan.

Muta T, Miyamoto T, Kamimura T, Kanda Y, Nohgawa M, Ueda Y, Iwato K, Sasaki O, Mori T, Uchida N, Iida S, Fukuda T, Atsuta Y, Sunami K.

Acta Haematol. 2018;139(1):35-44. doi: 10.1159/000484652. Epub 2018 Jan 17.

PMID:
29339642
6.

Bilateral Adrenal Hemorrhage in a Patient with Antiphospholipid Syndrome during Chronic Graft-versus-host Disease.

Minami M, Muta T, Adachi M, Higuchi M, Aoki K, Ogawa R.

Intern Med. 2018 May 15;57(10):1439-1444. doi: 10.2169/internalmedicine.9820-17. Epub 2017 Dec 27.

7.

Expansion of NKG2C-expressing Natural Killer Cells after Umbilical Cord Blood Transplantation in a Patient with Peripheral T-cell Lymphoma with Cytotoxic Molecules.

Muta T, Yoshihiro T, Jinnouchi F, Aoki K, Kochi Y, Shima T, Takenaka K, Ogawa R, Akashi K, Oshima K.

Intern Med. 2018 Mar 15;57(6):861-866. doi: 10.2169/internalmedicine.9437-17. Epub 2017 Dec 21.

8.

A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features.

Kawamoto K, Miyoshi H, Suzuki T, Kozai Y, Kato K, Miyahara M, Yujiri T, Choi I, Fujimaki K, Muta T, Kume M, Moriguchi S, Tamura S, Kato T, Tagawa H, Makiyama J, Kanisawa Y, Sasaki Y, Kurita D, Yamada K, Shimono J, Sone H, Takizawa J, Seto M, Kimura H, Ohshima K.

Haematologica. 2018 Jun;103(6):1018-1028. doi: 10.3324/haematol.2017.174177. Epub 2017 Dec 14.

9.

Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan.

Tsukune Y, Sasaki M, Odajima T, Sunami K, Takei T, Moriuchi Y, Iino M, Isoda A, Nakaya A, Muta T, Miyake T, Miyazaki K, Shimizu T, Nakajima K, Igarashi A, Nagafuji K, Kurihara T, Aoyama T, Sugimori H, Komatsu N.

Blood Cancer J. 2017 Nov 23;7(12):631. doi: 10.1038/s41408-017-0002-2. No abstract available.

10.

In vivo attraction of myeloma cells by renal cell carcinoma.

Muta T, Aoki K, Ogawa R, Sasaguri T.

Br J Haematol. 2017 Aug;178(4):499. doi: 10.1111/bjh.14765. Epub 2017 Jun 23. No abstract available.

PMID:
28643341
11.

Comparative analysis of pulmonary hypertension in patients treated with imatinib, nilotinib and dasatinib.

Minami M, Arita T, Iwasaki H, Muta T, Aoki T, Aoki K, Yamasaki S, Matsushima T, Kato K, Takenaka K, Tanimoto K, Kamimura T, Ogawa R, Akashi K, Miyamoto T.

Br J Haematol. 2017 May;177(4):578-587. doi: 10.1111/bjh.14608. Epub 2017 Mar 24.

PMID:
28340283
12.

Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified.

Kawamoto K, Miyoshi H, Yanagida E, Yoshida N, Kiyasu J, Kozai Y, Morikita T, Kato T, Suzushima H, Tamura S, Muta T, Kato K, Eto T, Seki R, Nagafuji K, Sone H, Takizawa J, Seto M, Ohshima K.

Eur J Haematol. 2017 May;98(5):459-466. doi: 10.1111/ejh.12856. Epub 2017 Mar 3.

PMID:
28129454
13.

Efficacy and adverse events of azacitidine in the treatment of hemodialysis patients with high-risk myelodysplastic syndrome.

Yoshihiro T, Muta T, Aoki K, Shimamoto S, Tamura Y, Ogawa R.

Rinsho Ketsueki. 2016 Aug;57(8):1004-10. doi: 10.11406/rinketsu.57.1004. Review. Japanese.

PMID:
27599416
14.

Ascites Retention during Mogamulizumab Treatment in a Patient with Adult T-cell Leukemia/lymphoma.

Shima T, Kamezaki K, Higashioka K, Takashima S, Yoshimoto G, Kato K, Muta T, Takenaka K, Iwasaki H, Miyamoto T, Akashi K.

Intern Med. 2016;55(13):1793-6. doi: 10.2169/internalmedicine.55.5987. Epub 2016 Jul 1.

15.

Mogamulizumab Treatment Prior to Allogeneic Hematopoietic Stem Cell Transplantation Induces Severe Acute Graft-versus-Host Disease.

Sugio T, Kato K, Aoki T, Ohta T, Saito N, Yoshida S, Kawano I, Henzan H, Kadowaki M, Takase K, Muta T, Miyawaki K, Yamauchi T, Shima T, Takashima S, Mori Y, Yoshimoto G, Kamezaki K, Takenaka K, Iwasaki H, Ogawa R, Ohno Y, Eto T, Kamimura T, Miyamoto T, Akashi K.

Biol Blood Marrow Transplant. 2016 Sep;22(9):1608-1614. doi: 10.1016/j.bbmt.2016.05.017. Epub 2016 May 21.

16.

Light Chain Deposition Disease in an Older Adult Patient Successfully Treated with Long-term Administration of Bortezomib, Melphalan and Prednisone.

Hiyamuta H, Yamada S, Matsukuma Y, Tsuchimoto A, Nakano T, Taniguchi M, Masutani K, Yoshimoto G, Muta T, Akashi K, Kitazono T, Tsuruya K.

Intern Med. 2016;55(10):1319-25. doi: 10.2169/internalmedicine.55.5752. Epub 2016 May 15.

17.

Screening of posttranscriptional regulatory molecules of IκB-ζ.

MaruYama T, Sayama A, Ishii KJ, Muta T.

Biochem Biophys Res Commun. 2016 Jan 15;469(3):711-5. doi: 10.1016/j.bbrc.2015.12.068. Epub 2015 Dec 19.

18.

[Clinical courses and risk factors for progression of smoldering multiple myeloma: a nationwide cohort study in Japan].

Takamatsu Y, Muta T.

Rinsho Ketsueki. 2015 Aug;56(8):1005-10. doi: 10.11406/rinketsu.56.1005. Japanese.

PMID:
26345559
19.

Control of IFN-γ production and regulatory function by the inducible nuclear protein IκB-ζ in T cells.

MaruYama T, Kobayashi S, Ogasawara K, Yoshimura A, Chen W, Muta T.

J Leukoc Biol. 2015 Sep;98(3):385-93. doi: 10.1189/jlb.2A0814-384R. Epub 2015 May 27.

20.

Epstein-Barr virus-positive diffuse large B-cell lymphoma following acute myeloid leukemia: a common clonal origin indicated by chromosomal translocation t(3;4)(p25;q21).

Higuchi M, Sasaki S, Kawadoko S, Uchiyama H, Yasui T, Kamihira T, Aoki K, Sasaguri T, Nakano R, Uchiyama A, Muta T, Ohshima K.

Int J Hematol. 2015 Oct;102(4):482-7. doi: 10.1007/s12185-015-1802-4. Epub 2015 May 8.

PMID:
25953309
21.

Long-term remission after high-dose chemotherapy followed by auto-SCT as consolidation for intravascular large B-cell lymphoma.

Kato K, Ohno Y, Kamimura T, Kusumoto H, Tochigi T, Jinnouchi F, Kohno K, Kuriyama T, Henzan H, Takase K, Kawano I, Kadowaki M, Nawata R, Muta T, Eto T, Iawasaki H, Ohshima K, Miyamoto T, Akashi K.

Bone Marrow Transplant. 2014 Dec;49(12):1543-4. doi: 10.1038/bmt.2014.189. Epub 2014 Aug 18. No abstract available.

PMID:
25133892
22.

Responses of macrophages to the danger signals released from necrotic cells.

Kimura T, Kobayashi S, Hanihara-Tatsuzawa F, Sayama A, MaruYama T, Muta T.

Int Immunol. 2014 Dec;26(12):697-704. doi: 10.1093/intimm/dxu080. Epub 2014 Aug 5.

PMID:
25096411
23.

Combination of bortezomib, thalidomide, and dexamethasone (VTD) as a consolidation therapy after autologous stem cell transplantation for symptomatic multiple myeloma in Japanese patients.

Takashima S, Miyamoto T, Kadowaki M, Ito Y, Aoki T, Takase K, Shima T, Yoshimoto G, Kato K, Muta T, Shiratsuchi M, Takenaka K, Iwasaki H, Teshima T, Kamimura T, Akashi K.

Int J Hematol. 2014 Aug;100(2):159-64. doi: 10.1007/s12185-014-1611-1. Epub 2014 Jun 14.

PMID:
24928523
24.

Ventricular fibrillation after bortezomib therapy in a patient with systemic amyloidosis.

Yamasaki S, Muta T, Higo T, Kusumoto H, Zaitsu E, Miyamoto T, Oda Y, Akashi K.

Hematol Rep. 2013 Sep 16;5(3):e12. doi: 10.4081/hr.2013.e12. eCollection 2013.

25.

Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma.

Miyamoto T, Yoshimoto G, Kamimura T, Muta T, Takashima S, Ito Y, Shiratsuchi M, Choi I, Kato K, Takenaka K, Iwasaki H, Takamatsu Y, Teshima T, Akashi K.

Int J Hematol. 2013 Sep;98(3):337-45. doi: 10.1007/s12185-013-1402-0. Epub 2013 Jul 23.

PMID:
23877150
26.

Bortezomib, doxorubicin and intermediate-dose dexamethasone (iPAD) therapy for relapsed or refractory multiple myeloma: a multicenter phase 2 study.

Takamatsu Y, Sunami K, Muta T, Morimoto H, Miyamoto T, Higuchi M, Uozumi K, Hata H, Tamura K; Kyushu Hematology Organization for Treatment Study Group (K-HOT).

Int J Hematol. 2013 Aug;98(2):179-85. doi: 10.1007/s12185-013-1389-6. Epub 2013 Jul 6.

PMID:
23832805
27.

Transcriptional and post-transcriptional regulation of IκB-ζ upon engagement of the BCR, TLRs and FcγR.

Hanihara F, Takahashi Y, Okuma A, Ohba T, Muta T.

Int Immunol. 2013 Sep;25(9):531-44. doi: 10.1093/intimm/dxt017. Epub 2013 Jun 1.

PMID:
23728777
28.

Efficacy and safety of aprepitant in allogeneic hematopoietic stem cell transplantation.

Uchida M, Kato K, Ikesue H, Ichinose K, Hiraiwa H, Sakurai A, Muta T, Takenaka K, Iwasaki H, Miyamoto T, Teshima T, Shiratsuchi M, Suetsugu K, Nagata K, Egashira N, Akashi K, Oishi R.

Pharmacotherapy. 2013 Sep;33(9):893-901. doi: 10.1002/phar.1294. Epub 2013 May 26.

29.

Effectiveness and safety of antiemetic aprepitant in Japanese patients receiving high-dose chemotherapy prior to autologous hematopoietic stem cell transplantation.

Uchida M, Ikesue H, Miyamoto T, Kato K, Suetsugu K, Ichinose K, Hiraiwa H, Sakurai A, Takenaka K, Muta T, Iwasaki H, Teshima T, Shiratsuchi M, Egashira N, Akashi K, Oishi R.

Biol Pharm Bull. 2013;36(5):819-24.

30.

Thioredoxin-interacting protein gene expression via MondoA is rapidly and transiently suppressed during inflammatory responses.

Kanari Y, Sato Y, Aoyama S, Muta T.

PLoS One. 2013;8(3):e59026. doi: 10.1371/journal.pone.0059026. Epub 2013 Mar 8.

31.

Cross-species analysis reveals evolving and conserved features of the nuclear factor κB (NF-κB) proteins.

Ryzhakov G, Teixeira A, Saliba D, Blazek K, Muta T, Ragoussis J, Udalova IA.

J Biol Chem. 2013 Apr 19;288(16):11546-54. doi: 10.1074/jbc.M113.451153. Epub 2013 Mar 18.

32.

Enhanced apoptosis by disruption of the STAT3-IκB-ζ signaling pathway in epithelial cells induces Sjögren's syndrome-like autoimmune disease.

Okuma A, Hoshino K, Ohba T, Fukushi S, Aiba S, Akira S, Ono M, Kaisho T, Muta T.

Immunity. 2013 Mar 21;38(3):450-60. doi: 10.1016/j.immuni.2012.11.016. Epub 2013 Feb 28.

33.

Essential role for Toll-like receptor 7 (TLR7)-unique cysteines in an intramolecular disulfide bond, proteolytic cleavage and RNA sensing.

Kanno A, Yamamoto C, Onji M, Fukui R, Saitoh S, Motoi Y, Shibata T, Matsumoto F, Muta T, Miyake K.

Int Immunol. 2013 Jul;25(7):413-22. doi: 10.1093/intimm/dxt007. Epub 2013 Feb 26.

PMID:
23446849
34.

Diffuse panbronchiolitis after humanized anti-CCR4 monoclonal antibody therapy for relapsed adult T-cell leukemia/lymphoma.

Kato K, Miyamoto T, Numata A, Nakaike T, Oka H, Yurino A, Kuriyama T, Mori Y, Yamasaki S, Muta T, Takenaka K, Iwasaki H, Teshima T, Akashi K.

Int J Hematol. 2013 Mar;97(3):430-2. doi: 10.1007/s12185-013-1278-z. Epub 2013 Feb 9.

PMID:
23397210
35.

Decrease in venous irritation by adjusting the concentration of injected bendamustine.

Watanabe H, Ikesue H, Tsujikawa T, Nagata K, Uchida M, Suetsugu K, Egashira N, Muta T, Kato K, Takenaka K, Ohga S, Matsushima T, Shiratsuchi M, Miyamoto T, Teshima T, Akashi K, Oishi R.

Biol Pharm Bull. 2013;36(4):574-8. Epub 2013 Feb 8.

36.

[Effect of bortezomib-based induction therapy on the peripheral blood stem cell harvest in multiple myeloma].

Muta T, Miyamoto T, Fujisaki T, Ohno Y, Kamimura T, Henzan T, Kato K, Takenaka K, Iwasaki H, Eto T, Takamatsu Y, Teshima T, Akashi K; Fukuoka Blood and Marrow Transplant Group (FBMTG).

Rinsho Ketsueki. 2013 Jan;54(1):109-16. Japanese.

PMID:
23391654
37.

Evaluation of the feasibility and efficacy of autologous stem cell transplantation in elderly patients with multiple myeloma.

Muta T, Miyamoto T, Fujisaki T, Ohno Y, Kamimura T, Kato K, Takenaka K, Iwasaki H, Eto T, Takamatsu Y, Teshima T, Akashi K; Fukuoka Blood and Marrow Transplant Group (FBMTG).

Intern Med. 2013;52(1):63-70. Epub 2013 Jan 1.

38.

Interleukin-10-induced neutrophil gelatinase-associated lipocalin production in macrophages with consequences for tumor growth.

Jung M, Weigert A, Tausendschön M, Mora J, Ören B, Sola A, Hotter G, Muta T, Brüne B.

Mol Cell Biol. 2012 Oct;32(19):3938-48. doi: 10.1128/MCB.00413-12. Epub 2012 Jul 30.

39.

Diffuse large B-cell lymphoma arising primarily at the stoma after bladder reconstruction using ileal conduit.

Muta T, Nakaike T, Fujisaki T, Shiraishi T, Ohshima K.

Intern Med. 2012;51(6):643-6. Epub 2012 Mar 15. Review.

40.

Iκb-ζ plays an important role in the ERK-dependent dysregulation of malaria parasite GPI-induced IL-12 expression.

Zhu J, Weinberg R, Wu X, Gowda NM, Muta T, Gowda DC.

IUBMB Life. 2012 Feb;64(2):187-93. doi: 10.1002/iub.592. Epub 2011 Nov 30.

41.

Identification of interleukin-1 receptor-associated kinase 1 as a critical component that induces post-transcriptional activation of IκB-ζ.

Ohba T, Ariga Y, Maruyama T, Truong NK, Inoue J, Muta T.

FEBS J. 2012 Jan;279(2):211-22. doi: 10.1111/j.1742-4658.2011.08416.x. Epub 2011 Nov 30.

42.

[Acute lung injury in a patient with concurrent diffuse large B-cell lymphoma and myelodysplastic syndrome].

Tokuyama T, Muta T, Yasunaga M, Nakanishi H, Ueda Y, Fujisaki T.

Gan To Kagaku Ryoho. 2011 Oct;38(10):1733-7. Japanese.

PMID:
21996978
43.

[B-cell lymphoma possessing t(14;18)(q32;q21)in a patient with rheumatoid arthritis receiving methotrexate treatment].

Nakanishi H, Muta T, Oshiro Y, Hida A, Mizuno Y, Yasunaga M, Ueda Y, Fujisaki T.

Gan To Kagaku Ryoho. 2011 Aug;38(8):1365-9. Japanese.

PMID:
21829083
44.

[Safety evaluation of bortezomib in multiple myeloma patients with severe renal failure].

Muta T, Nakanishi H, Yasunaga M, Senba S, Murakami H, Kan S, Ueda Y, Fujisaki T.

Gan To Kagaku Ryoho. 2011 Feb;38(2):237-41. Japanese.

PMID:
21368487
45.

[Chronic myeloid leukemia complicated with cerebellar hemorrhage and acute hydrocephalus successfully treated with imatinib and intensive supportive care].

Muta T, Sawada Y, Moriyama Y, Seike Y, Tokuyama T, Ueda Y, Fujisaki T.

Rinsho Ketsueki. 2010 Dec;51(12):1769-74. Japanese.

PMID:
21258187
46.

IκBζ is essential for natural killer cell activation in response to IL-12 and IL-18.

Miyake T, Satoh T, Kato H, Matsushita K, Kumagai Y, Vandenbon A, Tani T, Muta T, Akira S, Takeuchi O.

Proc Natl Acad Sci U S A. 2010 Oct 12;107(41):17680-5. doi: 10.1073/pnas.1012977107. Epub 2010 Sep 27.

47.

Pandemic (H1N1) 2009-associated ARDS rescued by neuraminidase inhibitors with emergency use of extracorporeal membrane oxygenation.

Nakanishi H, Muta T, Fujisaki T, Yoshitomi R, Kubo T, Yokota E.

Intern Med. 2010;49(17):1901-5. Epub 2010 Sep 1.

48.

Identification of BCAP-(L) as a negative regulator of the TLR signaling-induced production of IL-6 and IL-10 in macrophages by tyrosine phosphoproteomics.

Matsumura T, Oyama M, Kozuka-Hata H, Ishikawa K, Inoue T, Muta T, Semba K, Inoue J.

Biochem Biophys Res Commun. 2010 Sep 17;400(2):265-70. doi: 10.1016/j.bbrc.2010.08.055. Epub 2010 Aug 20.

PMID:
20728433
49.
50.

IkappaBzeta regulates T(H)17 development by cooperating with ROR nuclear receptors.

Okamoto K, Iwai Y, Oh-Hora M, Yamamoto M, Morio T, Aoki K, Ohya K, Jetten AM, Akira S, Muta T, Takayanagi H.

Nature. 2010 Apr 29;464(7293):1381-5. doi: 10.1038/nature08922. Epub 2010 Apr 11.

PMID:
20383124

Supplemental Content

Support Center